This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Smith + Nephew, Pall Corporation. Active years: 2007-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2007-2019
Title: Ed Margerrison: Inventor in Cell-Concentrate Technology
Introduction
Ed Margerrison is an inventor based in Germantown, Tennessee. His patent work includes methods for preparing cell concentrates from physiological solutions and applying them in the treatment of bone defects. He holds 4 patents.
Latest Patents
Margerrison’s listed patents address processing bone marrow aspirate, blood, or a mixture of the two to prepare a cell concentrate, including an osteogenic cell concentrate.
“Preparation of a Cell Concentrate from a Physiological Solution” describes methods and compositions for producing a cell concentrate using physiological-solution processing techniques. The patent highlights point-of-care applications and techniques that do not employ centrifugation.
“Method of Use of a Platelet/Nucleated Cell Concentrate from Bone Marrow or Blood to Treat a Bone Defect” concerns preparing and using a platelet or nucleated cell concentrate for bone-defect treatment. Its description likewise focuses on processing bone marrow aspirate, blood, or a mixture without centrifugation in particular embodiments.
Career Highlights
Margerrison has worked with Smith+Nephew and Pall Corporation. His patent portfolio reflects an emphasis on cell-concentrate preparation and potential applications in bone repair.
Collaborations
His listed coworkers include Samuel O. Sowemimo-Coker and Marcus Lee Scott. Their names appear alongside Margerrison’s professional and patent-related connections.
Conclusion
Ed Margerrison’s inventions focus on practical methods for preparing cell concentrates from blood and bone marrow, with particular attention to point-of-care processing and potential treatment of bone defects.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile